Increased focus on biosimilars and generics as well as demand for cell and gene therapies offer opportunities

Global pharmaceutical contract manufacturing and research services market

DUBLIN, 24 August 2022 (GLOBE NEWSWIRE) — The Pharmaceutical Contract Manufacturing & Research Services by Service (Manufacturing and Research), Enduser, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) – Global Forecast market research report to 2027 – Cumulative Impact of COVID-19 report added ResearchAndMarkets.com Offer.

The global pharmaceutical contract manufacturing and research services market size has been estimated at US$185.52 billion in 2021 and US$197.80 billion in 2022 and is expected to grow at a CAGR of 6.79% to reach 275 by 2027, reach $26 billion.

Market Segmentation and Coverage:
This research report categorizes the Pharmaceutical Contract Manufacturing & Research Services to forecast the revenue and analyze the trends in each of the following submarkets:

• Based on the service, the manufacturing and research market has been studied. Manufacturing is being further explored in the areas of Advanced Drug Delivery Formulations Packaging, API/Bulk Drugs, Finished Dose Formulations and Packaging. The finished dosage formulations are further studied in liquid formulations, semi-solid formulations and solid formulations. Research will continue to be explored in cardiology, inflammation and immunology, neuroscience, oncology and vaccines.

• Based on the end user, the market has been studied into Big Pharma, Generic Pharma, and Small & Medium-Sized Pharma.

• Based on region, the Americas, Asia-Pacific, and Europe, Middle East & Africa market has been studied. America is further studied in Argentina, Brazil, Canada, Mexico and the United States. The United States is further explored in California, Florida, Illinois, New York, Ohio, Pennsylvania and Texas. Asia Pacific continues to be explored in Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan and Thailand. Europe, Middle East and Africa are further explored in France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates and United Kingdom.

The story goes on

Competitive strategic window:
The Competitive Strategic Window analyzes the competitive landscape in terms of markets, applications and regions to help the vendor define an alignment or match between its capabilities and opportunities for future growth prospects. It describes the optimal or favorable suitability for vendors to adopt sequential merger and acquisition strategies, geographic expansion, research and development, and new product launch strategies to conduct further business expansion and growth during a forecast period.

FPNV positioning matrix:
The FPNV Positioning Matrix evaluates and categorizes the pharmaceutical contract manufacturing and research services market vendors based on business strategy (business growth, industry coverage, financial viability, and channel support) and product satisfaction (value for money, ease of use, product features). and customer support) that help businesses make better decisions and understand the competitive landscape.

Market share analysis:
Market share analysis offers the analysis of vendors considering their contribution to the overall market. It conveys the idea of ​​its revenue generation compared to other providers in this space in the overall market. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing the market share provides an idea of ​​the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance and merger characteristics.

market dynamics
driver

• Increasing number of CDMOs and increasing investment in advanced manufacturing technologies by CDMOs

• Increasing investment in drug development and discovery and advanced manufacturing technologies

• Growing volume of outsourcing by large pharmaceutical companies

limitations

occasions

• Growing demand for specialized testing services

• Increased focus on biosimilars and generics

• Growing demand for cell and gene therapies for targeted treatment

challenges

Main topics covered:

1 Introduction

2. Research methodology

3. Summary

4. Market Overview

5. Market Insights

6. Pharmaceutical Contract Manufacturing and Research Services Market, by Service

7. Pharmaceutical Contract Manufacturing and Research Services Market, by End User

8. Pharmaceutical Contract Manufacturing and Research Services Market in America

9. Asia-Pacific Pharmaceutical Contract Manufacturing and Research Services Market

10. Pharmaceutical Contract Manufacturing and Research Services Market in Europe, Middle East and Africa

11. Competitive Landscape

12. Company Usability Profiles

13. Appendix

companies mentioned

• AbbVie, Inc.

• Aenova Holding GmbH

• Albany Molecular Research, Inc.

• Baxter BioPharma Solutions

• Boehringer Ingelheim GmbH

• Catalent Pharma Solutions

• Charles River Laboratories International, Inc.

• Covance, Inc.

• Famar Health Services

• Grifols SA

• Cheering Life Sciences Limited

• Ligand Pharmaceuticals, Inc.

• lonza

• Pfizer, Inc.

• Pharmaceutical Product Development, LLC

• QuintilesIMS

• Recipharm AB.

• Valeant Pharmaceuticals International Inc.

• Cousin Pharma

• West Pharmaceutical Services, Inc.

For more information about this report, visit https://www.researchandmarkets.com/r/6ee2ua

Appendix

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900